Design, Synthesis and Some uses of Receptor-Specific Agonists and Antagonists of Vasopressin and Oxytocin
- 1 January 1993
- journal article
- review article
- Published by Taylor & Francis in Journal of Receptor Research
- Vol. 13 (1-4) , 195-214
- https://doi.org/10.3109/10799899309073655
Abstract
Selective agonists and antagonists are powerful tools for studies on AVP and OT receptors and on the physiological and pathophysiological roles of AVP and OT. Here we show how some of these peptides and their radiolabelled derivatives were designed. We also present examples of the currently available cyclic and linear OT and AVP agonists and antagonists from our laboratories.Keywords
This publication has 35 references indexed in Scilit:
- A POTENT NEW SYNTHETIC ANALOG OF VASOPRESSIN WITH RELATIVE AGONIST SPECIFICITY FOR THE PITUITARYEndocrinology, 1991
- OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor AntagonistScience, 1991
- Experimental uses of neurohypophysial hormone analogsTrends in Endocrinology & Metabolism, 1989
- Structure–Activity Relationships of Neurohypophyseal PeptidesPublished by Elsevier ,1987
- Chapter 16 Neurohypophyseal hormone receptor systems in brain and peripheryPublished by Elsevier ,1987
- Hormonal Stimulation of Phosphatidylinositol Breakdown, with Particular Reference to the Hepatic Effects of VasopressinBiochemical Society Transactions, 1979
- Basic Pharmacological Properties of Synthetic Analogues and Homologues of the Neurohypophysial HormonesPublished by Springer Nature ,1968
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963
- A SYNTHETIC PREPARATION POSSESSING BIOLOGICAL PROPERTIES ASSOCIATED WITH ARGININEVASOPRESSINJournal of the American Chemical Society, 1954
- The Synthesis of Oxytocin1Journal of the American Chemical Society, 1954